Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201028 · ClinicalTrials.gov registry record · NA
A Remote Delivered Lifestyle Therapeutics Program
A NA study, sponsored by Coastal Carolina University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04201028: Completed NA study, sponsored by Coastal Carolina University.
NCT04201028 is a NA study that has completed, run by Coastal Carolina University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201028, a NA study, has completed, sponsored by Coastal Carolina University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Heart disease is the leading cause of death in the United States. The overall risk for heart disease is a composite measure of various modifiable factors including blood pressure, cholesterol, and tobacco use; which are exacerbated by a sedentary lifestyle, unhealthy diet, and being overweight. Approximately 32% of the adult U.S. population has high blood pressure and 46% of them have uncontrolled hypertension. Successful management of high blood pressure and other cardiovascular risk is a complex process that requires significant lifestyle changes but adopting and adhering to these changes is challenging. A promise approach to overcoming these challenges is utilizing health coaching. The purpose of this research study is to compare at home devices for blood pressure and weight measurements (DEV) group compared to not using any at home devices Group (NODEV). Both groups will be supported throughout this study by meeting with obesity medicine doctor monthly in office and have a virtual health coaching visits throughout the study duration.
Primary Outcome
Investigators examined body weight changes between groups baseline (week 0) and post intervention (week 26).
Interventions
- BEHAVIORAL Video Conferencing Health Coaching with devices
- BEHAVIORAL Video Conferencing Health Coaching with no devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-01-06 |
| Est. Completion | 2022-02-12 |
| Phase | NA |
What the finished NCT04201028 record still lists
NCT04201028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Video Conferencing Health Coaching with devices is the first listed.
NCT04201028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04201028 about?
NCT04201028 is a clinical study titled "A Remote Delivered Lifestyle Therapeutics Program". Heart disease is the leading cause of death in the United States. The overall risk for heart disease is a composite measure of various modifiable factors including blood pressure, cholesterol, and tobacco use; which are exacerbated by a sedentary lifestyle, unhealthy diet, and being overweight. Appr...
What is the current status of trial NCT04201028?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-01-06. Estimated completion is 2022-02-12.
What interventions are being tested in trial NCT04201028?
The interventions under investigation include: Video Conferencing Health Coaching with devices (BEHAVIORAL), Video Conferencing Health Coaching with no devices (BEHAVIORAL).
Who is sponsoring clinical trial NCT04201028?
This trial is sponsored by Coastal Carolina University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04201028's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI